The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Polymorphisms in Plasmodium falciparum Chloroquine Resistance Transporter and Multidrug Resistance 1 Genes: Parasite Risk Factors That Affect Treatment Outcomes for P. falciparum Malaria After Artemether-Lumefantrine and Artesunate-Amodiaquine
Open accessAbstract
Adequate clinical and parasitologic cure by artemisinin combination therapies relies on the artemisinin component and the partner drug. Polymorphisms in the Plasmodium falciparum chloroquine resistance transporter (pfcrt) and P. falciparum multidrug resistance 1 (pfmdr1) genes are associated with decreased sensitivity to amodiaquine and lumefantrine, but effects of these polymorphisms on therapeutic responses to artesunate-amodiaquine (ASAQ) and artemether-lumefantrine (AL) have not been clearly defined. Individual patient data from 31 clinical trials were harmonized and pooled by using standardized methods from the WorldWide Antimalarial Resistance Network. Data for more than 7,000 patients were analyzed to assess relationships between parasite polymorphisms in pfcrt and pfmdr1 and clinically relevant outcomes after treatment with AL or ASAQ. Presence of the pfmdr1 gene N86 (adjusted hazards ratio = 4.74, 95% confidence interval = 2.29 – 9.78, P < 0.001) and increased pfmdr1 copy number (adjusted hazards ratio = 6.52, 95% confidence interval = 2.36–17.97, P < 0.001) were significant independent risk factors for recrudescence in patients treated with AL. AL and ASAQ exerted opposing selective effects on single-nucleotide polymorphisms in pfcrt and pfmdr1. Monitoring selection and responding to emerging signs of drug resistance are critical tools for preserving efficacy of artemisinin combination therapies; determination of the prevalence of at least pfcrt K76T and pfmdr1 N86Y should now be routine.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Partial residuals for the proportional hazards regression model
SCHOENFELD, D. (1982) · Biometrika · doi:10.1093/biomet/69.1.239 · Cited by 3,111
A molecular marker of artemisinin-resistant Plasmodium falciparum malaria
Ariey, F., Witkowski, B., Amaratunga, C., Beghain, J., Langlois, A.-C., Khim, N., Kim, S., Duru, V., Bouchier, C., Ma, L., et al. (2014) · Nature · doi:10.1038/nature12876 · Cited by 2,090
Self-citationFidock, D. (2000) · Molecular Cell · doi:10.1016/s1097-2765(00)00084-8 · Cited by 1,456
A Molecular Marker for Chloroquine-Resistant Falciparum Malaria
Djimdé, A., Doumbo, O. K., Cortese, J. F., Kayentao, K., Doumbo, S., Diourté, Y., Coulibaly, D., Dicko, A., Su, X.-Z., Nomura, T., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200101253440403 · Cited by 1,010
Self-citationPgh1 modulates sensitivity and resistance to multiple antimalarials in Plasmodium falciparum
Reed, M. B., Saliba, K. J., Caruana, S. R., Kirk, K., & Cowman, A. F. (2000) · Nature · doi:10.1038/35002615 · Cited by 866
Mefloquine resistance in Plasmodium falciparum and increased pfmdr1 gene copy number
Price, R. N., Uhlemann, A.-C., Brockman, A., McGready, R., Ashley, E., Phaipun, L., Patel, R., Laing, K., Looareesuwan, S., White, N. J., et al. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16767-6 · Cited by 853
Self-citationAndrews, K. G., Fergus, C. A., Aregawi, M. W., Cibulskis, R. E., & Zamani, G. (2014) · Cited by 569
Sidhu, A. B. S., Uhlemann, A., Valderramos, S. G., Valderramos, J., Krishna, S., & Fidock, D. A. (2006) · The Journal of Infectious Diseases · doi:10.1086/507115 · Cited by 415
Sisowath, C., Strömberg, J., Mårtensson, A., Msellem, M., Obondo, C., Björkman, A., & Gil, J. P. (2005) · The Journal of Infectious Diseases · doi:10.1086/427997 · Cited by 377
Self-citationPharmacokinetics and Pharmacodynamics of Lumefantrine (Benflumetol) in Acute Falciparum Malaria
Ezzet, F., van Vugt, M., Nosten, F., Looareesuwan, S., & White, N. J. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.3.697-704.2000 · Cited by 354
Self-citationClinical Pharmacokinetics and Pharmacodynamics of Artemether-Lumefantrine
White, N. J., van Vugt, M., & Ezzet, F. (1999) · Clinical Pharmacokinetics · doi:10.2165/00003088-199937020-00002 · Cited by 351
Price, R. N., Uhlemann, A.-C., van Vugt, M., Brockman, A., Hutagalung, R., Nair, S., Nash, D., Singhasivanon, P., Anderson, T. J. C., Krishna, S., et al. (2006) · Clinical Infectious Diseases · doi:10.1086/503423 · Cited by 317
Self-citationDuraisingh, M. T., Jones, P., Sambou, I., von Seidlein, L., Pinder, M., & Warhurst, D. C. (2000) · Molecular and Biochemical Parasitology · doi:10.1016/s0166-6851(00)00201-2 · Cited by 289
Artemisinin-based combination therapy for treating uncomplicated malaria
Sinclair, D., Zani, B., Donegan, S., Olliaro, P., & Garner, P. (2009) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007483.pub2 · Cited by 286
Resistance to Antimalarials in Southeast Asia and Genetic Polymorphisms in pfmdr1
Pickard, A. L., Wongsrichanalai, C., Purfield, A., Kamwendo, D., Emery, K., Zalewski, C., Kawamoto, F., Miller, R. S., & Meshnick, S. R. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.8.2418-2423.2003 · Cited by 279
Mutabingwa, T. K., Anthony, D., Heller, A., Hallett, R., Ahmed, J., Drakeley, C., Greenwood, B. M., & Whitty, C. J. (2005) · The Lancet · doi:10.1016/s0140-6736(05)66417-3 · Cited by 265
Martensson, A., Stromberg, J., Sisowath, C., Msellem, M. I., Gil, J. P., Montgomery, S. M., Olliaro, P., Ali, A. S., & Bjorkman, A. (2005) · Clinical Infectious Diseases · doi:10.1086/444460 · Cited by 203
Lim, P., Alker, A. P., Khim, N., Shah, N. K., Incardona, S., Doung, S., Yi, P., Bouth, D. M., Bouchier, C., Puijalon, O. M., et al. (2009) · Malaria Journal · doi:10.1186/1475-2875-8-11 · Cited by 179
Self-citationBenefits of using multiple first-line therapies against malaria
Boni, M. F., Smith, D. L., & Laxminarayan, R. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0804628105 · Cited by 172
The role of pfmdr1 in Plasmodium falciparum tolerance to artemether‐lumefantrine in Africa
Sisowath, C., Ferreira, P. E., Bustamante, L. Y., Dahlström, S., Mårtensson, A., Björkman, A., Krishna, S., & Gil, J. P. (2007) · Tropical Medicine & International Health · doi:10.1111/j.1365-3156.2007.01843.x · Cited by 164
Self-citationDuraisingh, M., Drakeley, C., Müller, O., Bailey, R., Snounou, G., Targett, G., Greenwood, B., & Warhurst, D. (1997) · Parasitology · doi:10.1017/s0031182096008487 · Cited by 163
Malmberg, M., Ferreira, P. E., Tärning, J., Ursing, J., Ngasala, B., Björkman, A., Mårtensson, A., & Gil, J. P. (2012) · The Journal of Infectious Diseases · doi:10.1093/infdis/jis747 · Cited by 140
Self-citationChoudhury, J. B. (2002) · Statistics in Medicine · doi:10.1002/sim.1070 · Cited by 116
The clinical efficacy of artemether/lumefantrine (Coartem®)
Makanga, M. M., & Krudsood, S. (2009) · Malaria Journal · doi:10.1186/1475-2875-8-s1-s5 · Cited by 110
Conrad, M. D., LeClair, N. P., Arinaitwe, E., Wanzira, H., Kakuru, A., Bigira, V., Muhindo, M. K., Kamya, M. R., Tappero, J. W., Greenhouse, B., et al. (2014) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiu141 · Cited by 100
Self-citationSomé, A. F., Sere, Y. Y., Dokomajilar, C., Zongo, I., Rouamba, N., Greenhouse, B., Ouédraogo, J., & Rosenthal, P. J. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01413-09 · Cited by 96
Self-citationEfficacy, Safety, and Selection of Molecular Markers of Drug Resistance by Two ACTs in Mali
DJIMDÉ, A. A., Fofana, B., Sagara, I., Sidibé, B., Touré, S., Dembele, D., Dama, S., Ouologuem, D., Dicko, A., & Doumbo, O. K. (2008) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.2008.78.455 · Cited by 90
Self-citationGadalla, N. B., Adam, I., El-Zaki, S.-E., Bashir, S., Mukhtar, I., Oguike, M. C., Gadalla, A. A. H., Mansour, F. A., Warhurst, D. C., El-Sayed, B., et al. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.05102-11 · Cited by 75
Self-citationFolarin, O. A., Bustamante, C., Gbotosho, G. O., Sowunmi, A., Zalis, M. G., ODUOLA, A. M. J., & Happi, C. T. (2011) · Acta Tropica · doi:10.1016/j.actatropica.2011.08.013 · Cited by 68
Bangchang, K. N., Karbwang, J., Thomas, C., Thanavibul, A., Sukontason, K., Ward, S. A., & Edwards, G. (1994) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1994.tb04271.x · Cited by 67
Swarthout, T. D., van den Broek, I. V., Kayembe, G., Montgomery, J. L., Pota, H., & Roper, C. (2006) · Tropical Medicine & International Health · doi:10.1111/j.1365-3156.2006.01710.x · Cited by 61
Mungthin, M., Khositnithikul, R., Sitthichot, N., Suwandittakul, N., Wattanaveeradej, V., Ward, S. A., & Na‐Bangchang, K. (2010) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.2010.10-0339 · Cited by 58
Ngasala, B., Malmberg, M., Carlsson, A. M., Ferreira, P. E., Petzold, M., Blessborn, D., Bergqvist, Y., Gil, J. P., Premji, Z., & Mårtensson, A. (2011) · Malaria Journal · doi:10.1186/1475-2875-10-64 · Cited by 53
Self-citationUhlemann, A., McGready, R. M., Ashley, E. A., Brockman, A., Singhasivanon, P., Krishna, S., White, N. J., Nosten, F. H., & Price, R. N. (2006) · The Journal of Infectious Diseases · doi:10.1086/509809 · Cited by 52
Self-citationArtemether-Lumefantrine: An Option for Malaria
Stover, K. R., King, S. T., & Robinson, J. (2012) · Annals of Pharmacotherapy · doi:10.1345/aph.1q539 · Cited by 38
Artemisinin Combination Therapies and Malaria Parasite Drug Resistance: The Game Is Afoot
Taylor, S. M., & Juliano, J. J. (2014) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiu142 · Cited by 30
Simpson, J. A., Jamsen, K. M., Anderson, T., Zaloumis, S. G., Nair, S., Woodrow, C. J., White, N. J., Nosten, F. H., & Price, R. N. (2013) · PLoS ONE · doi:10.1371/journal.pone.0069505 · Cited by 13
Self-citation
Cited by
Antimalarial drug resistance: linking Plasmodium falciparum parasite biology to the clinic
Blasco, B., Leroy, D., & Fidock, D. A. (2017) · Nature Medicine · doi:10.1038/nm.4381 · Cited by 576
WorldWide Antimalarial Resistance Network (WWARN) Lumefantrine PK/PD Study Group (2015) · BMC Medicine · doi:10.1186/s12916-015-0456-7 · Cited by 464
Uwimana, A., Umulisa, N., Venkatesan, M., Svigel, S. S., Zhou, Z., Munyaneza, T., Habimana, R. M., Rucogoza, A., Moriarty, L. F., Sandford, R., et al. (2021) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(21)00142-0 · Cited by 435
Self-citationHaldar, K., Bhattacharjee, S., & Safeukui, I. (2018) · Nature Reviews Microbiology · doi:10.1038/nrmicro.2017.161 · Cited by 431
Artemisinin Action and Resistance in Plasmodium falciparum
Tilley, L., Straimer, J., Gnädig, N. F., Ralph, S. A., & Fidock, D. A. (2016) · Trends in Parasitology · doi:10.1016/j.pt.2016.05.010 · Cited by 359
Metadata
- Authors
- Venkatesan, M., Gadalla, N. B., Stepniewska, K., Dahal, P., Nsanzabana, C., Moriera, C., Price, R. N., Mårtensson, A., Rosenthal, P. J., Dorsey, G., Sutherland, C. J., Guérin, P., Davis, T. M. E., Ménard, D., Adam, I., Ademowo, G., Arze, C., Baliraine, F. N., Berens-Riha, N., Björkman, A., Borrmann, S., Checchi, F., Desai, M., Dhorda, M., Djimdé, A. A., El-Sayed, B. B., Eshetu, T., Eyase, F., Falade, C., Faucher, J.-F., Fröberg, G., Grivoyannis, A., Hamour, S., Houzé, S., Johnson, J., Kamugisha, E., Kariuki, S., Kiechel, J.-R., Kironde, F., Kofoed, P.-E., LeBras, J., Malmberg, M., Mwai, L., Ngasala, B., Nosten, F., Nsobya, S. L., Nzila, A., Oguike, M., Otienoburu, S. D., Ogutu, B., Ouédraogo, J.-B., Piola, P., Rombo, L., Schramm, B., Somé, A. F., Thwing, J., Ursing, J., Wong, R. P. M., Zeynudin, A., Zongo, I., Plowe, C. V., Sibley, C. H., & _, _.
- Venue
- The American Society of Tropical Medicine and Hygiene
- Published
- 2014-10-01
- Volume
- 91
- Issue
- 4
- Pages
- 833-843
- ISSN
- 0002-9637 (ISSN-L)
- 1476-1645
- OpenAlex
- W2103439634
- Cited by
- 285
- References
- 37
- FWCI
- 18.69
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.